Saliva as a Biomarker in Oral Cancer
Tikrit Journal for Dental Sciences · 2022
DOI: 10.25130/tjds.10.1.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tikrit Journal for Dental Sciences, 2022. Verfasst von Mahde S. Hamad und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The prognosis for patients with oral cancer remains poor in spite of advances in therapy of many other malignancies. Early diagnosis and treatment remains the key to improved patient survival. The tumor markers are playing an increasingly important role in cancer detection and management. These laboratory-based tests are potentially useful in screening for early malignancy, aiding in cancer diagnosis, determining prognosis, surveillance following curative surgery for cancer, up-front predicting drug response or resistance, and monitoring therapy in advanced disease. Diagnostic tests for early detection include brush biopsy, toluidine blue staining, autofluorescence, salivary proteomics, DNA analysis, biomarkers and spectroscopy. This article focuses on biomarkers as valuable utility in risk assessment, clinical screening, diagnosis, and prognosis prediction of oral cancer in the era of precision medicine.
Zitieren
APA
Hamad, M. S., Sarhat, E. R., & Albarzanji, Z. N. M. (2022). Saliva as a Biomarker in Oral Cancer. Tikrit Journal for Dental Sciences. https://doi.org/10.25130/tjds.10.1.9
Vancouver
Hamad MS, Sarhat ER, Albarzanji ZNM. Saliva as a Biomarker in Oral Cancer. Tikrit Journal for Dental Sciences. 2022. doi:10.25130/tjds.10.1.9
BibTeX
@article{Hamad2022,
author = {Hamad, Mahde S. and Sarhat, Entedhar R. and Albarzanji, Zubaidah N. M},
title = {Saliva as a Biomarker in Oral Cancer},
journal = {Tikrit Journal for Dental Sciences},
year = {2022},
doi = {10.25130/tjds.10.1.9}
}
EUVIMED